Core Scientific (CORZ) Director Mark Adams Receives RSU Award

What Happened Mark Adams, a director of Core Scientific, received an award of 27,594 restricted stock units (RSUs) on July 30, 2026. The grant is reported at $0.00 per share (an award rather than a purchase), so no cash was paid by the insider. This is a compensation/retention grant rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-30; Form 4 filed: 2026-08-03 (appears to be filed late — 4 days after the transaction).
• Transaction type/code: Award/Grant (A).
• RSUs granted: 27,594; reported acquisition price: $0.00.
• Vesting: Two equal installments on July 30, 2027 and July 30, 2028, contingent on continued service (per footnote F1).
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Accession: 0000905148-26-003446.

Context RSU grants are common director compensation and are intended as long-term retention incentives; they do not represent an immediate market purchase or sale. RSUs typically convert to common shares only after vesting and may be subject to tax withholding at vesting. The late filing may be procedural; it does not by itself indicate trading intent.